Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

          In   connection   with  the  Annual  Report  on  Form  10-K  of  Elite
Pharmaceuticals,  Inc. (the  "Company")  for the year ended March 31, 2005 filed
with  the  Securities  and  Exchange  Commission  (the  "Report"),  I,  Mark  I.
Gittelman,  Chief  Financial  Officer of the  Company,  certify,  pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that:

(1) The Report fully  complies  with the  requirements  of Section  13(a) of the
Securities Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects,  the consolidated  financial  condition of the Company as of the dates
presented and consolidated  results of operations of the Company for the periods
presented.

Dated:  June 28, 2005


By: /s/ Mark Gittelman
    ---------------------------------
        Chief Financial Officer


This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.